首页> 外文OA文献 >PSY22 Cost analysis of Voriconazole versus Caspofungin for Primary Therapy of invasive Aspergillosis among High-Risk Hematologic Cancer Patients in China

【2h】

PSY22 Cost analysis of Voriconazole versus Caspofungin for Primary Therapy of invasive Aspergillosis among High-Risk Hematologic Cancer Patients in China

机译：PSY22伏立康唑和卡泊芬净在中国高危血液系统癌症患者侵袭性曲霉病的主要治疗中的成本分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Gao X.; Xue M.; Stephens J.; Chen Y.; Haider S.; Charbonneau C.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. COST ANALYSIS OF VORICONAZOLE VERSUS LIPOSOMAL AMPHOTERICIN B AND CASPOFUNGIN FOR PRIMARY THERAPY OF INVASIVE ASPERGILLOSIS AMONG HIGH-RISK HEMATOLOGIC CANCER PATIENTS IN LEBANON [J] . Helou G., Gao C., Xue M., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：静脉曲张抗脂质体两性霉素B和卡泊芬净治疗黎巴嫩高危血液病患者的侵袭性菌病的原发性治疗费用分析
2. Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain [J] . Santiago Grau, Jose Ramon Azanza, Isabel Ruiz, ClinicoEconomics and Outcomes Research . 2016,第67期

机译：伏立康唑和阿尼芬净联合抗真菌药与伏立康唑单药联合治疗西班牙侵袭性曲霉病的成本效益分析
3. Serum Galactomannan Versus a Combination of Galactomannan and Polymerase Chain Reaction-Based Aspergillus DNA Detection for Early Therapy of Invasive Aspergillosis in High-Risk Hematological Patients: A Randomized Controlled Trial [J] . Maria Aguado Jose, Vazquez Lourdes, Fernandez-Ruiz Mario, Clinical infectious diseases . 2015,第3期

机译：血清半乳甘露聚糖与半乳甘露聚糖和基于聚合酶链反应的曲霉DNA检测的组合，用于高危血液病患者的侵袭性曲霉病的早期治疗：一项随机对照试验
4. Is Primary Chemotherapy Useful for AiS Patients with Primary Invasive Breast Cancer [C] . S.M. Scholl, P. Beuzeboc, A.L. Harris, International Conference on "Adjuvant Therapy of Primary Breast Cancer" . 1998

机译：是主要的化疗，可用于AIS患有原发性侵袭性乳腺癌的患者
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain [O] . Santiago Grau, Jose Ramon Azanza, Isabel Ruiz, 2017

机译：伏立康唑联合阿尼芬净与抗真菌药联合伏立康唑单一疗法治疗西班牙侵袭性曲霉病的成本效益分析
7. Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin For Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Lebanon [O] . G Helou, C Gao, M Xue, 2016

机译：Voriconazole与脂质体两性素B和Caspofungin的成本分析，用于黎巴嫩高危血液癌患者侵袭性曲霉病的原发性治疗

PSY22 Cost analysis of Voriconazole versus Caspofungin for Primary Therapy of invasive Aspergillosis among High-Risk Hematologic Cancer Patients in China

著录项

引文网络

相似文献

相关主题

期刊订阅